Earnings Call · Q4 FY2024·2025-04-01

Q4 24EPS +34.88%·Rev n/aQ3 24EPS +42.86%·Rev n/aQ2 24EPS +42.86%·Rev n/aQ1 24EPS -40.52%·Rev n/a⚠ consensus missing

Vivos Therapeutics, Inc. VVOS

Bradford Amman — Chief Financial Officer

Kirk Huntsman — Chairman and Chief Executive Officer

−7.7%1d on move date−8.0% vs SPY3d−9.8%5d−11.6%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VVOS calls or request research access.

More VVOS calls Browse calls Request research access